Ownership of Regulatory Documentation. Neoprobe shall own all right, title and interest in and to all Regulatory Documentation, including Regulatory Documentation created by Neoprobe in performance of Neoprobe's obligations under this Agreement, subject to the Right of Reference to assigned Regulatory Documentation granted to AstraZeneca in Section 3.4. Confidential Treatment β Asterisked material has been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.
Appears in 2 contracts
Sources: Out Licence Agreement (Navidea Biopharmaceuticals, Inc.), Out Licence Agreement (Neoprobe Corp)